Adverse renal outcomes following targeted therapies in renal cell carcinoma: a systematic review and meta-analysis
Introduction: To clarify the prevalence of adverse renal outcomes following targeted therapies in renal cell carcinoma (RCC).Methods: A systematic search was performed in MEDLINE, EMBASE, and Cochrane Central Library. Studies that had reported adverse renal outcomes following targeted therapies in R...
Saved in:
Main Authors: | Song Ren (Author), Xiuling Chen (Author), Yang Zheng (Author), Tingwei Chen (Author), Xu Hu (Author), Yunlin Feng (Author), Shangqing Ren (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying an Immune-Related Gene ST8SIA1 as a Novel Target in Patients With Clear-Cell Renal Cell Carcinoma
by: Xu Hu, et al.
Published: (2022) -
Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis
by: Song Ren, et al.
Published: (2024) -
Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma
by: Yang Zheng, et al.
Published: (2023) -
Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells
by: Zhi-xiang Yuan, et al.
Published: (2016) -
Efficacy and safety of hypoxia-inducible factor-prolyl hydroxylase inhibitor treatment for anemia in chronic kidney disease: an umbrella review of meta-analyses
by: Song Ren, et al.
Published: (2023)